GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PAVmed Inc (NAS:PAVMW) » Definitions » Ending Cash Position

PAVMW (PAVmed) Ending Cash Position : $0.77 Mil (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is PAVmed Ending Cash Position?

PAVmed's Ending Cash Position for the quarter that ended in Sep. 2024 was $0.77 Mil.

PAVmed's quarterly Ending Cash Position declined from Mar. 2024 ($25.54 Mil) to Jun. 2024 ($25.50 Mil) and declined from Jun. 2024 ($25.50 Mil) to Sep. 2024 ($0.77 Mil).

PAVmed's annual Ending Cash Position declined from Dec. 2021 ($77.26 Mil) to Dec. 2022 ($39.74 Mil) and declined from Dec. 2022 ($39.74 Mil) to Dec. 2023 ($19.64 Mil).


PAVmed Ending Cash Position Historical Data

The historical data trend for PAVmed's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PAVmed Ending Cash Position Chart

PAVmed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.22 17.26 77.26 39.74 19.64

PAVmed Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.41 19.64 25.54 25.50 0.77

PAVmed Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PAVmed's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=39.744+-20.105
=19.64

PAVmed's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=25.499+-24.734
=0.77


PAVmed Ending Cash Position Related Terms

Thank you for viewing the detailed overview of PAVmed's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


PAVmed Business Description

Traded in Other Exchanges
Address
360 Madison Avenue, 25th Floor, New York, NY, USA, 10017
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.